This course will introduce you to insights about how our minds operate and help you understand the origins of implicit associations. You will also uncover some of your own biases and learn strategies for addressing them.
Continue Reading >>
Advocacy
Protecting the Integrated Model of Care
High-quality, integrated care delivered in the independent medical practice setting is worthy of protection as an alternative to care that is often more costly when furnished in the hospital setting. Read more...
Saving the In Office Ancillary Service Exception (IOASE)
Integrated models of care allow for better coordination across specialties, translating into higher quality, lower cost and more accessible care for patients. Read more...
Pathology Services Utilization
Recent data, including 2009-2013 Medicare data relating to the cost and utilization of anatomic pathology (AP) services, demonstrates that the GAO report fails to tell the full story about cost and utilization. Read more...
Recent Advocacy
DHPA Opposes Most Favored Nation Rule Announced by CMS
The MFN Rule could dramatically restrict patient access to infusion medications administered in physician offices, especially for patients with Crohn’s disease and ulcerative colitis, which are both major categories of inflammatory bowel disease (IBD).
Continue Reading >>
DHPA Supports USPSTF Recommendations to Begin CRC Screening at 45, Calls for More Research on Disparities in Communities of Color
While supporting the draft recommendations overall, Dr. Glenn Littenberg, DHPA chair of health policy, expressed some concern about USPSTF’s recommendations with respect to screening colonoscopy versus stool-based CRC screening.
Continue Reading >>
What is Health Equity? (RWJF Report)
Health equity is a cornerstone of the Robert Wood Johnson Foundation’s (RWJF) Culture of Health Action Framework, which aims to achieve a society in which everyone has an equal opportunity to live the healthiest life possible.
Continue Reading >>
Step Therapy Can Lead to Higher OOP Costs for Crohn’s Disease Patients (Avalere)
Avalere assessed potential implications of step therapy on patients with employer coverage to examine total OOP and payer costs. Step therapy—also known as “fail first”—is a common form of utilization management that health plans use to control costs. Step therapy requires patients to try a preferred drug before gaining access to the drug prescribed by […]
Continue Reading >>
- « Previous Page
- 1
- …
- 8
- 9
- 10
- 11
- 12
- …
- 23
- Next Page »